Illuminating Aberrant mRNA Events in CLL

    Cancer Discovery
    |September 16, 2018
    PubMed

    Insights

    Aberrant intronic polyadenylation is common in chronic lymphocytic leukemia (CLL), affecting numerous genes. This mRNA processing error creates non-functional tumor suppressor proteins, potentially driving cancer growth.

    Area of Science:

    • Molecular Biology
    • Oncology
    • Biochemistry

    Background:

    • Chronic lymphocytic leukemia (CLL) is a heterogeneous B-cell malignancy.
    • Aberrant mRNA processing is increasingly recognized in cancer development.
    • The role of intronic polyadenylation in CLL pathogenesis remains largely unexplored.

    Discussion:

    • Intronic polyadenylation, a non-canonical mRNA processing event, was investigated in CLL.
    • This phenomenon was found to be widespread, affecting multiple genes critical for cellular function.
    • The study identified specific genes targeted by aberrant intronic polyadenylation in CLL patients.

    Key Insights:

    • Aberrant intronic polyadenylation leads to the production of truncated proteins.
    • These truncated proteins often lose their tumor suppressor functions.
    • In some instances, the altered proteins may acquire oncogenic properties, promoting cancer progression.

    Outlook:

    • Targeting aberrant mRNA processing pathways could offer novel therapeutic strategies for CLL.
    • Further research is needed to fully elucidate the mechanisms by which truncated proteins contribute to CLL.
    • Developing methods to detect and quantify intronic polyadenylation events may aid in CLL diagnosis and prognosis.

    Related Concept Videos

    Regulated mRNA Transport02:22

    Regulated mRNA Transport

    In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
    7.0K
    pre-mRNA Processing02:01

    pre-mRNA Processing

    In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
    Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...
    57.6K
    Nuclear Export of mRNA02:31

    Nuclear Export of mRNA

    Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
    8.8K
    Nuclear Export of mRNA02:31

    Nuclear Export of mRNA

    5.4K